The government is continuing to study the draft implementing legislation for Articles 15 and 16 of the EU Tobacco Products Directive and is discussing the drafts with the Commission and other Member States. We are aware of concerns raised by businesses affected and are working to try to ensure that the system adopted is effective, efficient and proportionate in tackling the trade in illicit tobacco products which puts public health at risk and avoids the payment of duty.<\/p>
<\/p>
We will continue to assess the impact of the legislation and the timetable for implementation as the drafts develop, and we welcome and encourage those affected to continue to contribute their views and concerns.<\/p>"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} } , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "creator" : {"_about" : "http://data.parliament.uk/members/3192", "label" : {"_value" : "Biography information for Lord Palmer"} } , "date" : {"_value" : "2017-10-18", "_datatype" : "dateTime"} , "dateTabled" : {"_value" : "2017-10-18", "_datatype" : "dateTime"} , "ddpCreated" : {"_value" : "2017-10-18T20:58:43.067Z", "_datatype" : "dateTime"} , "ddpModified" : [{"_value" : "2017-10-20T14:45:09.988Z", "_datatype" : "dateTime"} , {"_value" : "2017-11-01T13:22:09.518Z", "_datatype" : "dateTime"} ], "hansardHeading" : {"_value" : "Tobacco: EU Law"} , "houseId" : {"_value" : "2"} , "humanIndexable" : {"_value" : "true", "_datatype" : "boolean"} , "identifier" : {"_value" : "HL2224"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "parliamentNumber" : "57", "published" : {"_value" : "true", "_datatype" : "boolean"} , "publisher" : {"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } , "questionFirstAnswered" : [{"_value" : "2017-11-01T12:50:11.93Z", "_datatype" : "dateTime"} ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the potential impact on business resulting from the implementation, in their current form, of Articles 15 and 16 of the EU Tobacco Products Directive.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "session" : ["2017/19"], "sessionNumber" : {"_value" : "1"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3192", "label" : {"_value" : "Biography information for Lord Palmer"} } , "tablingMemberPrinted" : [{"_value" : "Lord Palmer"} ], "title" : "House of Lords Tabled Parliamentary Question 2017/19 HL2224", "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "HL2224", "version" : "2", "writtenParliamentaryQuestionType" : "Ordinary"} , {"_about" : "http://data.parliament.uk/resources/600471", "AnswerDate" : {"_value" : "2016-10-26", "_datatype" : "dateTime"} , "AnsweringBody" : [{"_value" : "Department of Health"} ], "QuestionStatus" : {"_value" : "Tabled"} , "answer" : {"_about" : "http://data.parliament.uk/resources/600471/answer", "answerText" : {"_value" : "
Clinical commissioning groups are responsible for commissioning cataract surgery for their local populations. Patients have the right to start consultant-led treatment within 18 weeks of referral for non-urgent conditions, or alternatively have the right to ask for an alternative provider who can see them sooner. All patients should be treated without unnecessary delay and according to their clinical priority.<\/p>
Where National Institute for Health and Care Excellence (NICE) guidance does not exist on a particular treatment, it is for local National Health Service commissioners to make funding decisions based on an assessment of the available evidence and on the basis of an individual patient\u2019s clinical circumstances. However, in light of concerns about lengthy waits for treatment and unacceptable variations in care, the Secretary of State has asked NICE to bring forward its guidance on cataracts from 2018 to 2017. This will provide NHS commissioners with evidence based guidance from NICE and ensure patients have access to the most effective treatment as early as possible.<\/p>
The Government has not made an assessment of the effect of hospital-initiated postponement of cataract surgery on patients\u2019 sight or of the impact of innovative technologies; we anticipate that these aspects will be considered by NICE in their assessment.<\/p>"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} } , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "creator" : {"_about" : "http://data.parliament.uk/members/2488", "label" : {"_value" : "Biography information for Lord Harrison"} } , "date" : {"_value" : "2016-10-12", "_datatype" : "dateTime"} , "dateTabled" : {"_value" : "2016-10-12", "_datatype" : "dateTime"} , "ddpCreated" : {"_value" : "2016-10-12T22:34:43.277Z", "_datatype" : "dateTime"} , "ddpModified" : [{"_value" : "2016-10-12T22:45:27.564Z", "_datatype" : "dateTime"} , {"_value" : "2016-10-25T16:50:11.460Z", "_datatype" : "dateTime"} ], "hansardHeading" : {"_value" : "Cataracts: Surgery"} , "houseId" : {"_value" : "2"} , "humanIndexable" : {"_value" : "true", "_datatype" : "boolean"} , "identifier" : {"_value" : "HL2224"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "parliamentNumber" : "56", "published" : {"_value" : "true", "_datatype" : "boolean"} , "publisher" : {"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } , "questionFirstAnswered" : [{"_value" : "2016-10-25T16:19:13.843Z", "_datatype" : "dateTime"} ], "questionText" : "To ask Her Majesty\u2019s Government, in the light of the statement by the Secretary of State for Health on 10 August that any patient who needs cataract surgery should get it without delay, what is their assessment of the impact on cataract surgery waiting times and local capacity to deliver cataract treatment of a higher priority being afforded to such treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "session" : ["2016/17"], "sessionNumber" : {"_value" : "2"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2488", "label" : {"_value" : "Biography information for Lord Harrison"} } , "tablingMemberPrinted" : [{"_value" : "Lord Harrison"} ], "title" : "House of Lords Tabled Parliamentary Question 2016/17 HL2224", "type" : "http://data.parliament.uk/schema/parl#WrittenParliamentaryQuestion", "uin" : "HL2224", "version" : "1", "writtenParliamentaryQuestionType" : "Ordinary"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : "http://purl.org/linked-data/api/vocab#Page"} }